ML19325D143

Opposes NRC Regulations 10CFR35.100,35.200 & 35.300 in 861016 Fr Re Administration of Radioactive Drug Only If Fda Has Accepted Notice of Claimed Investigational Exemption for New Drug or Approved New Drug Application for Drug
Person / Time
ML19325D143
Issue date:	09/13/1988
From:	Schlegel J AMERICAN PHARMACEUTICAL ASSOCIATION
To:	Zech L NRC COMMISSION (OCM)
Shared Package
ML19325D099	List: ML19325D098 ML19325D109 ML19325D110 ML19325D126 ML19325D131 ML19325D143 ML19325D144 ML19325D151 ML19325D164 ML19325D180 ML19325D181
References
RULE-PRM-35-9 NUDOCS 8910190054
Download: ML19325D143 (2)
v • d • e

v t e Similar Documents from Schlegel J, AMERICAN PHARMACEUTICAL ASSOCIATION
Category:CORRESPONDENCE-LETTERS [Table view]Some use of "" in your query was not closed by a matching "". Category:INCOMING CORRESPONDENCE [Table view]Some use of "" in your query was not closed by a matching "". Category:PROFESSIONAL/INDUSTRIAL ASSOCIATION TO NRC [Table view]Some use of "" in your query was not closed by a matching "".

Navigation menu